Table 2.
n | % | |
---|---|---|
Patient demographic | ||
Sex | ||
Male | 8561 | 53.6 |
Female | 7406 | 46.4 |
Age (years) | ||
< 65 | 5442 | 34.1 |
65–80 | 9394 | 58.8 |
> 80 | 1131 | 7.1 |
Ethnicity | ||
White | 15,405 | 96.5 |
Non-white | 562 | 3.5 |
Index multiple deprivation | ||
1—least deprived | 2557 | 16.0 |
2 | 3222 | 20.2 |
3 | 3297 | 20.7 |
4 | 3354 | 21.0 |
5—most deprived | 3537 | 22.2 |
Comorbidity score* | ||
0 | 6589 | 41.3 |
1 | 3473 | 21.8 |
2–3 | 2428 | 15.2 |
4 + | 3477 | 21.8 |
Cancer features | ||
Year of diagnosis | ||
2009/2010 | 3280 | 20.5 |
2011 | 3212 | 20.1 |
2012 | 3302 | 20.7 |
2013 | 3028 | 19.0 |
2014/2015 | 3145 | 19.7 |
Stage | ||
Stage IA–IB | 2884 | 18.1 |
Stage IIA–IIB | 1930 | 12.1 |
Stage IIIA–IIIB | 4547 | 28.5 |
Stage IV | 4843 | 30.3 |
Unknown | 1763 | 11.0 |
Route of diagnosis | ||
Emergency presentation | 2012 | 12.6 |
GP referral | 4062 | 25.4 |
Inpatient elective | 287 | 1.8 |
Other outpatient | 2161 | 13.5 |
TWW | 7318 | 45.8 |
Missing | 127 | 0.8 |
Lung cancer type | ||
Carcinoid | 273 | 1.7 |
NSCLC | 13,268 | 83.1 |
SCLC | 2426 | 15.2 |
Anti-cancer treatment | ||
Number of treatments | ||
0 | 537 | 3.4 |
1 | 7216 | 45.2 |
2 | 7727 | 48.4 |
3 | 487 | 3.0 |
Treatment modality | ||
NSCLC only | ||
No treatment | 496 | 3.7 |
Surgery | 4945 | 37.3 |
Chemo and radio | 3750 | 28.3 |
Chemotherapy only | 2769 | 20.9 |
Radiotherapy only | 1308 | 9.9 |
SCLC only | ||
No treatment | 21 | 0.9 |
Surgery | 102 | 4.2 |
Chemo and radio | 1921 | 79.2 |
Chemotherapy only | 302 | 12.5 |
Radiotherapy only | 80 | 3.3 |
NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer. Deprivation quintiles presented. *Charlson index of comorbidity presented. TWW, two-week wait; GP, general practitioner (primary care)